Stoke Therapeutics Stock Forecast - Accumulation Distribution
| STOK Stock | USD 29.46 0.59 1.96% |
Stoke Stock outlook is based on your current time horizon. Although Stoke Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Stoke Therapeutics' systematic risk associated with finding meaningful patterns of Stoke Therapeutics fundamentals over time.
As of now, the RSI of Stoke Therapeutics' share price is approaching 45. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Stoke Therapeutics, making its price go up or down. Momentum 45
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.63) | EPS Estimate Current Year 0.0563 | EPS Estimate Next Year (3.15) | Wall Street Target Price 37.125 | EPS Estimate Current Quarter (0.57) |
Using Stoke Therapeutics hype-based prediction, you can estimate the value of Stoke Therapeutics from the perspective of Stoke Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Stoke Therapeutics using Stoke Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Stoke using crowd psychology based on the activity and movement of Stoke Therapeutics' stock price.
Stoke Therapeutics Short Interest
An investor who is long Stoke Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Stoke Therapeutics and may potentially protect profits, hedge Stoke Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 20.2261 | Short Percent 0.225 | Short Ratio 12.29 | Shares Short Prior Month 9.3 M | 50 Day MA 30.764 |
Stoke Relative Strength Index
Stoke Therapeutics Hype to Price Pattern
Investor biases related to Stoke Therapeutics' public news can be used to forecast risks associated with an investment in Stoke. The trend in average sentiment can be used to explain how an investor holding Stoke can time the market purely based on public headlines and social activities around Stoke Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Stoke Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Stoke Therapeutics.
Stoke Therapeutics Implied Volatility | 1.33 |
Stoke Therapeutics' implied volatility exposes the market's sentiment of Stoke Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Stoke Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Stoke Therapeutics stock will not fluctuate a lot when Stoke Therapeutics' options are near their expiration.
Stoke Therapeutics after-hype prediction price | USD 29.46 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Stoke Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Stoke contract
Based on the Rule 16, the options market is currently suggesting that Stoke Therapeutics will have an average daily up or down price movement of about 0.0831% per day over the life of the 2026-03-20 option contract. With Stoke Therapeutics trading at USD 29.46, that is roughly USD 0.0245 . If you think that the market is fully incorporating Stoke Therapeutics' daily price movement you should consider acquiring Stoke Therapeutics options at the current volatility level of 1.33%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Stoke Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Stoke Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Stoke Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Stoke Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Stoke Therapeutics' open interest, investors have to compare it to Stoke Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Stoke Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Stoke. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Stoke Therapeutics Additional Predictive Modules
Most predictive techniques to examine Stoke price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Stoke using various technical indicators. When you analyze Stoke charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 25603.71 | 0.0508 |
| Check Stoke Therapeutics Volatility | Backtest Stoke Therapeutics | Information Ratio |
Stoke Therapeutics Trading Date Momentum
| On January 26 2026 Stoke Therapeutics was traded for 29.46 at the closing time. The top price for the day was 30.29 and the lowest listed price was 28.75 . There was no trading activity during the period 0.0. Lack of trading volume on January 26, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.71% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Stoke Therapeutics to competition |
Other Forecasting Options for Stoke Therapeutics
For every potential investor in Stoke, whether a beginner or expert, Stoke Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Stoke Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Stoke. Basic forecasting techniques help filter out the noise by identifying Stoke Therapeutics' price trends.Stoke Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Stoke Therapeutics stock to make a market-neutral strategy. Peer analysis of Stoke Therapeutics could also be used in its relative valuation, which is a method of valuing Stoke Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Stoke Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Stoke Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Stoke Therapeutics shares will generate the highest return on investment. By undertsting and applying Stoke Therapeutics stock market strength indicators, traders can identify Stoke Therapeutics entry and exit signals to maximize returns.
Stoke Therapeutics Risk Indicators
The analysis of Stoke Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Stoke Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting stoke stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.28 | |||
| Standard Deviation | 4.54 | |||
| Variance | 20.65 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Stoke Therapeutics
The number of cover stories for Stoke Therapeutics depends on current market conditions and Stoke Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Stoke Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Stoke Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Stoke Therapeutics Short Properties
Stoke Therapeutics' future price predictability will typically decrease when Stoke Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Stoke Therapeutics often depends not only on the future outlook of the potential Stoke Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Stoke Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 54 M | |
| Cash And Short Term Investments | 216.9 M |
Check out Historical Fundamental Analysis of Stoke Therapeutics to cross-verify your projections. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 1.172 | Return On Assets | Return On Equity |
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.